Evo Visian® ICL Launches in the U.S.; an Evolutionary Vision Correction Procedure to Treat Nearsightedness is Now Available at Coastal Vision Medical Group
27 avr. 2022 13h00 HE
|
Coastal Vision Medical Group (coastalvisionmedical.com)
CHINO, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- EVO Visian® ICL ("EVO") is an evolutionary, clinically-proven implantable lens that corrects common vision problems such as nearsightedness and...